Generic veterinary medicines
Generic veterinary medicines emanate from the same molecule as the originator. They are equally high quality, safe and efficient as the originators. Generics are thoroughly assessed, authorised and regulated by the competent authorities before entering the market. They need to comply with the stringent quality, safety and efficacy requirements for the animal, human health and the environment. To operate in Europe, the generic producers also have to follow rigorous manufacturing standards and quality controls known as good manufacturing practice (GMP).
Generic medicines are authorised and placed on the market after intellectual property and other protection periods associated to the originator product have expired. This may take up to 25 years. When entering the market, generics will be produced with up-to-date technology, enhanced analytical capacities and materials complying with the most recent regulations.
- Availability
Generics are present in every EU member state, across all therapeutic areas and for a wide range of different species – both major and minor species. They help to fill gaps in markets where originators are not present (mainly smaller markets), or for species and indications where there is no originator medicine available.
- Convenience
Many generics contain improvements in presentation, taste or physical properties, making them easier to administer and better dosed to the animal.
- Compliance
By widening the range of available medicines to more species and indications, the generic veterinary industry enables better treatment rates across Europe. The improved features also enhance and facilitate adherence to therapies increasing animal welfare.
- Efficacy
Generics are proved to be effective according to strict requirements and have a demonstrated bioequivalence with the originator products. They are equally efficient as the reference product and in addition, may include new therapeutic indications.
- Safety
Due to their late arrival, generics are authorised according to the most recent rigorous safety requirements and quality controls. Improved formulations and more suitable and better adapted features provide advantages without compromising the safety of the product to the animals, end users, public health and the environment.
- Savings
Generics stimulate a healthy competitive environment. The introduction of one or several generics will, in most cases, lead to a price decrease in that market segment.
Market study 2024
Assessment of the generic veterinary product market in Europe
Market study 2021
Generic and added value veterinary product market in Europe
Market study 2019
Assessment of the generic veterinary product market in Europe